The Open Markets Institute filed an amicus brief in the U.S. Court of Appeals for the Ninth Circuit supporting Innovative Health, LLC in Innovative Health v. Biosense Webster urging the court to uphold a jury verdict finding Biosense Webster guilty of violating federal antitrust law by using its dominant position in the cardiac-mapping market to block competition from lower-cost medical device reprocessors.
In this issue, we explore a recent bipartisan bill calling for a break up healthcare conglomerates that own everything from insurance companies to hospitals to pharmacies. We also launched a new report urging policymakers to prepare for the bursting of the AI bubble.
The Center for Journalism and Liberty is now the Center for Media and Digital Governance (CMDG) at the Open Markets Institute. The new name reflects the Center’s expansive body of work examining how concentrated technology power, digital infrastructure, and artificial intelligence are reshaping journalism, information markets, democratic governance, and public debate.
OMI Europe director Max von Thun speaks on how Europe is undermining its own digital sovereignty by weakening enforcement of the DMA, DSA, and competition law in response to U.S. pressure, leaving citizens, startups, and democratic institutions more vulnerable to dominant tech platforms.